Gary Hennerberg
Directeur/Membre du Conseil chez FINDIT
Fortune : 739 625 $ au 30/04/2024
Profil
Gary Hennerberg is currently the Chief Marketing Officer & Director at BioRegenx, Inc. since 2016 and the Secretary & Director at Findit, Inc. since 2024.
He completed his undergraduate degree at Fort Hays State University in 1978.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOREGENX INC
1,72% | 08/03/2024 | 16 436 000 ( 1,72% ) | 739 620 $ | 30/04/2024 |
FINDIT INC PFD A
0,00% | 08/03/2024 | 108 ( 0,00% ) | 5 $ | 30/04/2024 |
Postes actifs de Gary Hennerberg
| Sociétés | Poste | Début |
|---|---|---|
| FINDIT | Directeur/Membre du Conseil | 08/03/2024 |
Anciens postes connus de Gary Hennerberg
| Sociétés | Poste | Fin |
|---|---|---|
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Directeur/Membre du Conseil | - |
Formation de Gary Hennerberg
| Fort Hays State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FINDIT | Technology Services |
| Entreprise privées | 1 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
